Bentley Pharmaceuticals (BNT) Misses Q1 EPS Views
Bentley Pharmaceuticals Inc. (NYSE: BNT) reports Q1 earnings of $0.05 per share, below the consensus of $0.12. Revenues came in at $40 million, versus the consensus of $34.9 million.
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- Hewlett-Packard Company (HPQ) Tops Q2 EPS by 7c; Guides Q3 Below the Street, Raises FY12 Outlook
- Taro Pharmaceutical Industries (TARO) Nearly Doubles Q1 EPS to 1.06
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
